BioXell SpA suffered a collapse in its share price following news that its vitamin D3 analogue elocalcitol failed to meet the primary endpoint of a Phase IIb trial in overactive bladder (OAB). (BioWorld International)
No Abstract BioWorld Today CorrespondentKeyNeurotek Pharmaceuticals AG completed a second closing of an internal Series C round, raising the total value of the deal to €8.2 million (US$10.9 million).Although no new investors bought into the company, all its "main existing investors" did participate, Magdeburg, Germany-based KeyNeurotek said.Those include Munich-based Deutsche Venture Capital, IBG Beteiligungsgesellschaft, of Magdeburg, and Bonn-based KfW.
No Abstract BioWorld International CorrespondentKeyNeurotek Pharmaceuticals AG completed a second closing of an internal Series C round, raising the total value of the deal to €8.2 million (US$10.9 million).Although no new investors bought into the company, all its "main existing investors" did participate, Magdeburg, Germany-based KeyNeurotek said.Those include Munich-based Deutsche Venture Capital, IBG Beteiligungsgesellschaft, of Magdeburg, and Bonn-based KfW.
Shares in Intercell AG received a significant boost Tuesday on news that the FDA approved its Japanese Encephalitis Virus (JEV) vaccine Ixiaro late Monday. (BioWorld International)
The Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus. (BioWorld International) BioWorld International CorrespondentThe Merck Serono division of Merck KGaA has launched a new corporate venture capital arm, Merck Serono Ventures, to give the company early visibility on emerging innovation in its parent's core area of focus.
Kenta Biotech AG raised CHF12 million (US$10.1 million) in an internal Series B round that will fund the entry into the clinic of its second therapeutic antibody. (BioWorld International)
